Puey Ling Chia
Puey Ling Chia, MBBS, MRCP, FRACP, earned the IASLC Lung Cancer Fellowship Award for 2015-2016 and will study under the mentorship of Professor Thomas John, MBBS, FRACP, PhD, at The Austin Hospital as part of the Olivia Newton-John Cancer Research Institute in the Oncology Unit.
For most patients with malignant mesothelioma (MM), there is only one chemotherapy regimen that historically can prolong life. Furthermore, incidents of MM continues to increase globally. MM typically causes a strong inflammatory reaction and leads to an increase in molecules known as Ephrins. Dr. Chia plans to use a large collection of tissue samples to study the correlation between Ephrins and the clinical characteristics of patients. The goal is to study not just the microenvironment in specific tumors, but also the immunological profile in MM. The findings may substantially add to our understanding of MM and contribute to establishing important therapeutic options in the future.
Dr. Chia’s project also seeks to build on previous work that established antibodies found in the inflammation as novel therapies for cancer and determining the potential to use these antibodies to treat MM. Additionally, her project has the support of two well-established translational researchers in the same institution: A/Prof. Thomas John and Prof. Andrew Scott.
Dr. Chia has always been keen to work in the field of translation and clinical research related to thoracic oncology and is committed toward a long-term career in lung cancer research.